1.
Points to consider in the clinical application of genomic sequencing
by ACMG Board of Directors
Genetics in medicine, 2012-08, Vol.14 (8), p.759-761
2.
Technical report: Ethical and policy issues in genetic testing and screening of children
by Ross, Lainie Friedman
Genetics in medicine, 2013-03, Vol.15 (3), p.234-245
3.
Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents
by Botkin, Jeffrey R
American journal of human genetics, 2015-07-02, Vol.97 (1), p.6-21
4.
Direct-to-consumer genetic testing for predicting sports performance and talent identification: Consensus statement
by Webborn, Nick
British journal of sports medicine, 2015-12, Vol.49 (23), p.1486-1491
5.
Noninvasive Prenatal Genetic Testing: Current and Emerging Ethical, Legal, and Social Issues
by Minear, Mollie A
Annual review of genomics and human genetics, 2015-08-24, Vol.16 (1), p.369-398
6.
Incorporating genomics into breast and prostate cancer screening: assessing the implications
by Chowdhury, Susmita
Genetics in medicine, 2013-06, Vol.15 (6), p.423-432
7.
Managing incidental genomic findings: legal obligations of clinicians
by Clayton, Ellen Wright
Genetics in medicine, 2013-08, Vol.15 (8), p.624-629
8.
Are the gene-patent storm clouds dissipating? A global snapshot
by Liddicoat, Johnathon
Nature biotechnology, 2015-04, Vol.33 (4), p.347-352
9.
Neurogenetic evidence in the courtroom: a randomised controlled trial with German judges
by Fuss, Johannes
Journal of medical genetics, 2015-11, Vol.52 (11), p.730-737
10.
"Trust is not something you can reclaim easily": patenting in the field of direct-to-consumer genetic testing
by Sterckx, S
Genetics in medicine, 2013, Vol.15 (5), p.382-387
11.
Legal uncertainty in the area of genetic diagnostic testing
by Berthels, Nele
Nature biotechnology, 2009-10, Vol.27 (10), p.903-909
12.
Unleashing the power of human genetic variation knowledge: New Zealand stakeholder perspectives
by Gu, Yulong
Genetics in medicine, 2011-01, Vol.13 (1), p.26-38
13.
Implementing risk-stratified screening for common cancers: a review of potential ethical legal and social issues
by Hall, A E
Journal of public health (Oxford, England), 2014-06-01, Vol.36 (2), p.285-291
14.
Noninvasive prenatal testing: limitations and unanswered questions
by Lutgendorf, Monica A
Genetics in medicine, 2014-04, Vol.16 (4), p.281-285
15.
Regulatory changes raise troubling questions for genomic testing
by Evans, Barbara J
Genetics in medicine, 2014-11, Vol.16 (11), p.799-803
16.
Minimizing liability risks under the ACMG recommendations for reporting incidental findings in clinical exome and genome sequencing
by Evans, Barbara J
Genetics in medicine, 2013-12, Vol.15 (12), p.915-920
17.
Developing context-specific next-generation sequencing policy
by Curnutte, Margaret Ann
Nature biotechnology, 2016-05-06, Vol.34 (5), p.466-470
18.
Personalized medicine and genetic malpractice
by Marchant, Gary E
Genetics in medicine, 2013-12, Vol.15 (12), p.921-922
19.
Public opinion on policy issues in genetics and genomics
by Almeling, Rene
Genetics in medicine, 2014-06, Vol.16 (6), p.491-494
20.
Revisiting the Wilson-Jungner criteria: how can supplemental criteria guide public health in the era of genetic screening?
by Petros, Michael
Genetics in medicine, 2012-01, Vol.14 (1), p.129-134
